LeonaBio (LONA) Cash from Operations (2019 - 2026)
LeonaBio (LONA) posted quarterly Cash from Operations of 20903000.0 for Q1 2026, down 42.54% year-over-year from 36376230.57 in Q1 2025, and down 7.76% quarter-over-quarter from 19397000.0 in Q4 2025.
LeonaBio (LONA) Cash from Operations (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has reported Cash from Operations for 8 consecutive years, with 20903000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations fell 42.54% year-over-year to 20903000.0; the TTM figure through Mar 2026 stood at 51967000.0 (up 39.6% YoY), while the FY2025 annual figure was 45729000.0, up 52.94% from the prior year.
- Cash from Operations slipped to 20903000.0 in Q1 2026 per LONA's latest filing, from 19397000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 4668000.0 in Q3 2025 and bottomed at 26293000.0 in Q4 2023.
- Historically, Cash from Operations has averaged 19824941.18 across 5 years, with a median of 21640000.0 in 2022.
- Annual changes were most pronounced in 2022 — Cash from Operations tumbled 154.07% — and 2025, when it soared 79.72%.
- LeonaBio's Cash from Operations stood at 15667000.0 in 2022, then tumbled by 67.82% to 26293000.0 in 2023, then rose by 1.06% to 26013000.0 in 2024, then gained by 25.43% to 19397000.0 in 2025, then slipped by 7.76% to 20903000.0 in 2026.
- Business Quant data shows LONA's Cash from Operations at 20903000.0 in Q1 2026, 19397000.0 in Q4 2025, and 4668000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | LeonaBio | 180.91 Mn | 129.85 Mn | - | -16.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.90 Mn |
| Mar 31, 2026 | -20.90 Mn |
| Dec 31, 2025 | -19.40 Mn |
| Dec 31, 2025 | -19.40 Mn |
| Sep 30, 2025 | -4.67 Mn |
| Sep 30, 2025 | -4.67 Mn |
| Jun 30, 2025 | -7.00 Mn |
| Jun 30, 2025 | -7.00 Mn |
| Mar 31, 2025 | -14.67 Mn |
| Mar 31, 2025 | -14.67 Mn |
| Dec 31, 2024 | -26.01 Mn |
| Dec 31, 2024 | -26.01 Mn |
| Sep 30, 2024 | -23.02 Mn |
| Sep 30, 2024 | -23.02 Mn |
| Jun 30, 2024 | -22.33 Mn |
| Jun 30, 2024 | -22.33 Mn |
| Mar 31, 2024 | -25.80 Mn |
| Mar 31, 2024 | -25.80 Mn |
| Dec 31, 2023 | -26.29 Mn |
| Dec 31, 2023 | -26.29 Mn |